Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
6 studies found for:    19745215 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Basic and Clinical Research on Applying Blood Fix to Treat Critical H1N1 Patients
Conditions: Virus Diseases;   Respiratory Tract Diseases;   Respiratory Tract Infections;   Influenza;   Orthomyxoviridae Infections
Interventions: Biological: split-virion, non-adjuvanted H1N1 vaccine of 15 μg;   Other: blood fix
2 Completed Evaluation of Influenza H1N1 Vaccine in Adults With Lymphoid Malignancies on Chemotherapy
Conditions: Lymphoma;   Multiple Myeloma;   Influenza A Virus, H1N1 Subtype
Intervention: Biological: AS03-adjuvanted H1N1 pandemic influenza vaccine
3 Completed Immunogenicity, Safety, and Tolerability of MF59-Adjuvanted Versus Non-Adjuvanted Influenza Vaccines in Patients With HIV-1 Infection
Conditions: H1N1 Influenza Virus;   Human Immunodeficiency Virus Type 1 (HIV-1) Infection
Interventions: Biological: Focetria®;   Biological: Begrivac®
4 Completed Immunogenicity, Safety, and Tolerability of an MF59-Adjuvanted Versus Non-Adjuvanted Influenza Vaccines in Patients With Chronic Pulmonary Disease, Chronic Heart Disease, or Diabetes Mellitus
Conditions: H1N1 Influenza Virus;   Chronic Pulmonary Disease;   Chronic Heart Disease;   Diabetes Mellitus
Interventions: Biological: Focetria®;   Biological: Fluad®;   Biological: Begrivac®
5 Completed Clinical Trial to Compare the Immunogenicity, Safety, and Tolerability of an Adjuvanted A(H1N1) Influenza Vaccine Versus Non-Adjuvanted A(H1N1) Influenza Vaccines in Patients With Invasive Solid Tumors
Conditions: H1N1 Influenza Virus;   Invasive Solid Tumors
Interventions: Biological: adjuvanted A(H1N1) influenza vaccine;   Biological: non-adjuvanted A(H1N1) influenza vaccine
6 Completed Safety and Immunogenicity of A/H1N1v Vaccines in Healthy Adults
Condition: Influenza
Interventions: Biological: MF59 H1N1 vaccine;   Biological: Plain H1N1 vaccine

Indicates status has not been verified in more than two years